Manager TitleAgeSince
Chief Executive Officer 60 2003-12-31
Comptroller/Controller/Auditor 45 -
Director TitleAgeSince
Director/Board Member 60 2003-12-31
Director/Board Member 62 2008-09-30
Director/Board Member 56 2008-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-5.03%-13.54% - - 770K
-4.27%-0.88%+157.47%+115.38% 114M
+2.33%0.00%-23.07%-42.47% 105M
-0.60%-5.04%-19.83%-66.80% 83.31M
+11.61%-2.26%+41.80%+4.22% 69.95M
Average +0.81%-2.10%+39.09%+2.58% 93.05M
Weighted average by Cap. +1.38%-1.80%+45.29%+9.33%
Logo Bio-Synectics, Inc.
Bio-Synectics, Inc. is a Korea-based company principally engaged in the development of nanoparticle technology and drug delivery systems. The Company's products include HydroCurcumin and HydroCoQ10. HydroCurcumin is a material that can overcome curcumin's poor solubility. HydroCoQ10 is a material that can overcome poor solubility of Coenzyme Q10 (CoQ10). The Company is also engaged in the development of function food and cosmetic materials. The Company distributes its products within domestic market and to overseas markets.
Employees
-
  1. Stock Market
  2. Stocks
  3. A281310 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!